Home
NewsNewsINVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.
INVO Fertility, Inc., a healthcare services fertility company that helps people get advanced reproductive treatment by setting up, acquiring as well as running fertility clinics along with related businesses and technologies, on March 5, 2026, went ahead and announced that its Wisconsin clinic would start using time-lapse incubation technology. This integration shows that INVO is indeed dedicated to providing modern, high-quality lab care and creative patient solutions, as well as to improving the quality of labs and clinics across its growing network.
According to COO of INVO, April McGhee, “INVO Fertility is proud to introduce this time-lapse incubation technology as part of our ongoing focus on quality and innovation and the expansion of additional patient service offerings. This technology enhances the tools available to our embryology teams while aligning with our commitment to delivering thoughtful, patient-centred fertility care.”
INVO is looking out to improve its clinics and help its clinical and laboratory teams and also throttle its mission of providing accessible, patient-centred fertility care by using proven new ideas like time-lapse incubation. This adoption shows that the company is keeping its promise to invest in cutting-edge technologies that improve the treatment journey for patients. It is also part of the company's larger plan to responsibly integrate cutting-edge reproductive technologies that provide real value to patients and doctors.
Remarks CEO Steve Shum, “Our approach to innovation is intentional. We focus on technologies that may enhance quality and outcomes while staying true to our mission of expanding access to fertility care through continuous, responsible innovation.”
Send Enquiry for this Story
Previous News
CSG.BIO Confirms Acquisition of Hanabusa IVF, Asian Egg Bank to Expand Global Fertility Network and Expertise
Next News
IVF Academy USA Adds Powerful Thrust to Fertility Care Services with Advanced Training and Skilled Workforce Solutions
Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.
Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.
Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.
Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.
Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.
The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.
